MS is most commonly diagnosed in young women, at a time when many will still be considering starting or expanding their family. As more disease modifying treatments (DMTs) become available, what are the latest recommendations regarding their use during pregnancy?
The last newsletter of 2021 covers interesting reads about vaccines, DTM, and the effects of winter on people with MS as well as team updates and exclusive teasers.
Currently there is no cure for MS. Yet, there are more and more treatments that help patients manage it better. Find our more about the recent treatments.
The European Commission has approved a subcutaneous formulation of ocrelizumab to treat adults with MS and it is now available to people with relapsing forms of multiple sclerosis as well as primary progressive multiple sclerosis.
ChatGPT vs. neurologist: what do patient prefer? High efficacy treatment in paediatric-onset MS to significantly reduce disability progression. Updated guidance on cladribine for aggressive RRMS. PwMS with cognitive impairment tend to report a worse quality of life compared to PwMS without it.